Global consumer healthcare company iNova Pharmaceuticals continues its growth trajectory in Asia with the Philippine launch of DURO-TUSS®, a science-backed cough solution that joins iNova’s growing product portfolio in the country.
The launch event gathered healthcare professionals and medical experts to introduce the brand’s commitment to providing proven, effective, and reliable cough relief for Filipino families.
Tailored Relief for Every Type of Cough
DURO-TUSS® offers tailored relief for every type of cough with two powerful formulations designed to target specific cough types. Butamirate Citrate (DURO-TUSS BC™) is available in a 60 ml syrup and a 50 mg sustained-release tablet. This formulation provides dual-action relief by suppressing cough and easing breathing, making it ideal for treating dry cough.
On the other hand, Ambroxol Hydrochloride (DURO-TUSS AX™) is available in a 60 ml syrup and a 75 mg sustained-release tablet, offering effective relief for coughs associated with mucus and congestion.
Ambroxol Hydrochloride (DURO-TUSS AX™) offers triple action relief for cough with phlegm, it thins and loosens mucus, clears chest congestion, and protects the lungs from phlegm buildup.
DURO-TUSS® is now available at leading pharmacies nationwide. It carries a comprehensive range of prescription and over-the-counter cough relief medications tailored to treat either dry cough or cough with phlegm.
Always read the product label and follow the directions for use. Consult your doctor for more information or if symptoms persist.
